FINT
FINAL DECISION TRANSACTION PROCESSED BY IB
01/31/2023
Back to search
Official data from USPTO
ALMOTREX
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
44
Latest update
01/31/2023
Trademark type
Combined
Nice classes
5
Filing date
07/30/2014
Registration date
09/22/2015
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/08/2022
Last transaction
04/08/2022
Responsible office
United States Patent and Trademark Office
Status code
709
Official register
Principal Register
Drawing code
5
Owner type
99
Owner location
ES
Examiner
NADELMAN, ANDREA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ALMIRALL, S.A.
Almirall AG
Representatives
Nancy DiConza Fross Zelnick Lehrman & Zissu, P.C.
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticalspreparations for the treatment of disorders of the central nervous systemincluding migraine
Publications
History of USPTO decisions and trademark events.
44 publications found
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
12/29/2022
BDFU
BIRTH/DEATH MERGER PROCESSED BY USPTO
12/16/2022
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
12/08/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/28/2022
C71T
CANCELLED SECTION 71
04/08/2022
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
09/22/2020
RNWL
INTERNATIONAL REGISTRATION RENEWED
12/27/2019
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/11/2019
CORV
REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
05/23/2017
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
03/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2017
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
06/23/2016
FICS
FINAL DISPOSITION NOTICE SENT TO IB
03/23/2016
FIMP
FINAL DISPOSITION PROCESSED
03/23/2016
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12/22/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
09/22/2015
GPNX
NOTIFICATION PROCESSED BY IB
07/11/2015
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/07/2015
PUBO
PUBLISHED FOR OPPOSITION
07/07/2015
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/24/2015
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
06/24/2015
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06/17/2015
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
06/04/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/02/2015
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/29/2015
GNSL
LETTER OF SUSPENSION E-MAILED
04/29/2015
CNSL
SUSPENSION LETTER WRITTEN
04/29/2015
XAEC
EXAMINER'S AMENDMENT ENTERED
04/29/2015
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/29/2015
GNEA
EXAMINERS AMENDMENT E-MAILED
04/29/2015
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/29/2015
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
12/29/2014
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
12/29/2014
RFNT
REFUSAL PROCESSED BY IB
12/19/2014
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
11/21/2014
RFRR
REFUSAL PROCESSED BY MPU
11/21/2014
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
11/20/2014
ALIE
ASSIGNED TO LIE
11/19/2014
CNRT
NON-FINAL ACTION WRITTEN
11/19/2014
MAFR
APPLICATION FILING RECEIPT MAILED
11/18/2014
DOCK
ASSIGNED TO EXAMINER
11/14/2014
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/14/2014
SDRC
SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB
11/13/2014
Continuous trademark protection
Get notified about every new filing that threatens ALMOTREX or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.